United States - English - NLM (National Library of Medicine)

padagis israel pharmaceuticals ltd - acyclovir (unii: x4hes1o11f) (acyclovir - unii:x4hes1o11f) - acyclovir cream is a herpes simplex virus (hsv) deoxynucleoside analogue dna polymerase inhibitor indicated for the treatment of recurrent herpes labialis (cold sores) in immunocompetent adults and adolescents 12 years of age and older. acyclovir cream is contraindicated in patients with known hypersensitivity to acyclovir, valacyclovir, or any component of the formulation. risk summary acyclovir is minimally absorbed systemically following topical route of administration, and maternal use is not expected to result in fetal exposure to the acyclovir cream [see clinical pharmacology (12.3) ]. experience with topical acyclovir use in pregnant women over several decades, based on published literature including observational studies, has not identified a drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes. animal reproduction studies with systemic exposure of acyclovir have been conducted. refer to acyclovir prescribing information for additional details. the estimated b

United States - English - NLM (National Library of Medicine)

viona pharmaceuticals inc - acyclovir (unii: x4hes1o11f) (acyclovir - unii:x4hes1o11f) - acyclovir cream, 5% is a herpes simplex virus (hsv) deoxynucleoside analogue dna polymerase inhibitor indicated for the treatment of recurrent herpes labialis (cold sores) in immunocompetent adults and adolescents 12 years of age and older. acyclovir cream is contraindicated in patients with known hypersensitivity to acyclovir, valacyclovir, or any component of the formulation. risk summary acyclovir is minimally absorbed systemically following topical route of administration, and maternal use is not expected to result in fetal exposure to the acyclovir cream [see clinical pharmacology (12.3)]. experience with topical acyclovir use in pregnant women over several decades, based on published literature including observational studies, has not identified a drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes. animal reproduction studies with systemic exposure of acyclovir have been conducted. refer to acyclovir prescribing information for additional details. the estima

Kenya - English - Pharmacy and Poisons Board

adcock ingram ltd. p.o. box 101674-00101 nairobi - adco acyclovir cream - cream - each 1g contains acyclovir 0.05gms - antivirals for topical use

United States - English - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - acyclovir (unii: x4hes1o11f) (acyclovir - unii:x4hes1o11f) - acyclovir cream is a herpes simplex virus (hsv) deoxynucleoside analogue dna polymerase inhibitor indicated for the treatment of recurrent herpes labialis (cold sores) in immunocompetent adults and adolescents 12 years of age and older. acyclovir cream is contraindicated in patients with known hypersensitivity to acyclovir, valacyclovir, or any component of the formulation. risk summary acyclovir is minimally absorbed systemically following topical route of administration, and maternal use is not expected to result in fetal exposure to the acyclovir cream [see clinical pharmacology (12.3)] . experience with topical acyclovir use in pregnant women over several decades, based on published literature including observational studies, has not identified a drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes. animal reproduction studies with systemic exposure of acyclovir have been conducted. refer to acyclovir prescribing information for additional details.

United States - English - NLM (National Library of Medicine)

amneal pharmaceuticals llc - acyclovir (unii: x4hes1o11f) (acyclovir - unii:x4hes1o11f) - acyclovir cream, 5% is a herpes simplex virus (hsv) deoxynucleoside analogue dna polymerase inhibitor indicated for the treatment of recurrent herpes labialis (cold sores) in immunocompetent adults and adolescents 12 years of age and older. acyclovir cream is contraindicated in patients with known hypersensitivity to acyclovir usp, valacyclovir, or any component of the formulation. risk summary acyclovir is minimally absorbed systemically following topical route of administration, and maternal use is not expected to result in fetal exposure to the acyclovir cream [see clinical pharmacology (12.3)]. experience with topical acyclovir use in pregnant women over several decades, based on published literature including observational studies, has not identified a drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes. animal reproduction studies with systemic exposure of acyclovir have been conducted. refer to acyclovir prescribing information for additional details. the es

Kenya - English - Pharmacy and Poisons Board

biopharmaltd 32547-00600 - acyclovir cream - cream - composition: acyclovir b.p. 5% w/w - antivirals for topical use

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

kotra pharma (m) sdn. bhd. - acyclovir -

United States - English - NLM (National Library of Medicine)

taro pharmaceuticals u.s.a., inc. - acyclovir (unii: x4hes1o11f) (acyclovir - unii:x4hes1o11f) - acyclovir 50 mg in 1 g - acyclovir ointment usp, 5% is indicated in the management of initial genital herpes and in limited non-life-threatening mucocutaneous herpes simplex virus infections in immunocompromised patients. acyclovir ointment usp, 5% is contraindicated in patients who develop hypersensitivity to the components of the formulation.

Kenya - English - Pharmacy and Poisons Board

universal corporation limited club road plot no:13777 p.o.box 1748-00902 kikuyu - acyclovir - cream - each 10 grams contains acyclovir 5%w/w cream. - antivirals for systemic use:

United States - English - NLM (National Library of Medicine)

bausch health us, llc - acyclovir (unii: x4hes1o11f) (acyclovir - unii:x4hes1o11f) - acyclovir 50 mg in 1 g - zovirax cream is a herpes simplex virus (hsv) deoxynucleoside analogue dna polymerase inhibitor indicated for the treatment of recurrent herpes labialis (cold sores) in immunocompetent adults and adolescents 12 years of age and older. zovirax cream is contraindicated in patients with known hypersensitivity to acyclovir, valacyclovir, or any component of the formulation. risk summary acyclovir is minimally absorbed systemically following topical route of administration, and maternal use is not expected to result in fetal exposure to the zovirax cream [see clinical pharmacology (12.3)] . experience with topical acyclovir use in pregnant women over several decades, based on published literature including observational studies, has not identified a drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes. animal reproduction studies with systemic exposure of acyclovir have been conducted. refer to acyclovir prescribing information for additional details. the estimated backgr